| Field | Row 1 |
|---|---|
| adsh | 0001558370-25-007582 |
| cik | 1509261 |
| name | REZOLUTE, INC. |
| sic | 2834 |
| countryba | US |
| stprba | CA |
| cityba | REDWOOD CITY |
| zipba | 94065 |
| bas1 | 275 SHORELINE DRIVE, SUITE 500 |
| bas2 | |
| baph | 650-206-4507 |
| countryma | US |
| stprma | CA |
| cityma | REDWOOD CITY |
| zipma | 94065 |
| mas1 | 275 SHORELINE DRIVE, SUITE 500 |
| mas2 | |
| countryinc | US |
| stprinc | NV |
| ein | 273440894 |
| former | ANTRIABIO, INC. |
| changed | 20130114 |
| afs | 4-NON |
| wksi | 0 |
| fye | 0630 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q3 |
| filed | 20250513 |
| accepted | 2025-05-13 16:26:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | rzlt-20250331x10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001558370-25-007582 | 20250331 | Additional Paid In Capital | 461931000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Acquisition Of Treasury Shares In Exchange For Issuing Pre Funded Warrant Liability | 5697000.0000 | USD | 3 | 0001558370-25-007582 | |||
| 0001558370-25-007582 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5589000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 45000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Assets | 132737000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Cash And Cash Equivalents At Carrying Value | 14596000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Common Stock Shares Issued | 60542914.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Embedded Derivative Fair Value Of Embedded Derivative Liability | 500000.0000 | USD | 0 | us-gaap/2024 | Derivative Instrument Risk= Embedded Derivative Financial Instruments; | ||
| 0001558370-25-007582 | 20240331 | Increase Decrease In Accounts Payable | 230000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Increase Decrease In Accounts Payable | 2151000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 558000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Liabilities | 12170000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Liabilities And Stockholders Equity | 94739000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Marketable Securities Noncurrent | 1514000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Net Cash Provided By Used In Operating Activities | -47080000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Net Income Loss | -17050000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20250331 | Net Income Loss | -18914000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Operating Lease Payments | 559000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -30000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 122000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Payments For Repurchase Of Common Stock | 3000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Prepaid Expense And Other Assets Current | 1779000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Research And Development Expense | 15283000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Share Based Compensation | 4750000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20230630 | Stockholders Equity | 37000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20231231 | Stockholders Equity | 91728000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Stockholders Equity | 70861000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Stock Issued During Period Shares New Issues | 11250000.0000 | shares | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Underwritten Public Offering; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 8219.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Stock Repurchased And Retired During Period Shares | 3000000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 123000.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2021; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 50812332.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 123000.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2021; | ||
| 0001558370-25-007582 | 20250331 | Proceeds From Issuance Of Private Placement | 6000000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Proceeds From Stock Options Exercised | 761000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Profit Loss | -45483000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Profit Loss | -50022000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Research And Development Expense | 36654000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1905000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240630 | Cash And Cash Equivalents At Carrying Value | 70396000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Common Stock Shares Authorized | 165000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Comprehensive Income Net Of Tax | -49900000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Depreciation And Amortization | 23000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Liabilities And Stockholders Equity | 132737000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Marketable Securities Noncurrent | 263000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Net Cash Provided By Used In Investing Activities | -14887000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Net Income Loss | -68500000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Net Income Loss | -50022000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Operating Expenses | 47321000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Operating Lease Right Of Use Asset | 1880000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240229 | Payments For Repurchase Of Common Stock | 3000.0000 | USD | 0 | us-gaap/2024 | Agreement= Securities Exchange Agreement; | ||
| 0001558370-25-007582 | 20250331 | Research And Development Expense | 40664000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Retained Earnings Accumulated Deficit | -379466000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20231231 | Stockholders Equity | -289418000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20241130 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 2525883.0000 | shares | 0 | 0001558370-25-007582 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 2999384.0000 | shares | 3 | 0001558370-25-007582 | Class Of Warrant Or Right= Exchange Pre Funded Warrants; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 5525267.0000 | shares | 3 | 0001558370-25-007582 | Class Of Warrant Or Right= Pre Funded Warrants; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Shares New Issues | 1500000.0000 | shares | 3 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 10000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Stock Repurchased And Retired During Period Shares | 3000000.0000 | shares | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 69901565.0000 | shares | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 3750000.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2024; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 1323338.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2021; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 5621053.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 2100000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Accrued Clinical Current | 2325000.0000 | USD | 0 | 0001558370-25-007582 | |||
| 0001558370-25-007582 | 20240630 | Additional Paid In Capital | 450473000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Assets Current | 128653000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -10106000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001558370-25-007582 | 20240630 | Common Stock Shares Issued | 53245824.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Comprehensive Income Net Of Tax | -18935000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Deposits Assets Noncurrent | 1838000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Depreciation And Amortization | 29000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | General And Administrative Expense | 3812000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Increase Decrease In Accrued Liabilities | 1057000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Increase Decrease In Accrued Liabilities | -1181000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Liabilities Current | 9606000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Marketable Securities Current | 56478000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Operating Lease Liability Current | 615000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -21000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20250331 | Payments To Acquire Marketable Securities | 100686000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Preferred Stock Shares Authorized | 400000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001558370-25-007582 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 85766000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Retained Earnings Accumulated Deficit | -329444000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Stockholders Equity | 377367000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240331 | Stockholders Equity | 40000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Stockholders Equity | 461931000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240630 | Stock Issued During Period Shares New Issues | 1500000.0000 | shares | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Private Placement; | ||
| 0001558370-25-007582 | 20240731 | Stock Issued During Period Shares New Issues | 1500000.0000 | shares | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Private Placement; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 5000.0000 | shares | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value Exercise Of Pre Funded Warrants | -6000.0000 | USD | 3 | 0001558370-25-007582 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240331 | Stock Repurchased And Retired During Period Value | 5697000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240331 | Stock Repurchased And Retired During Period Value | 3000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 5621053.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 39910160.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 58229644.0000 | shares | 3 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 123000.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2021; | ||
| 0001558370-25-007582 | 20240630 | Accounts Payable Current | 4901000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 2059000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Accumulated Other Comprehensive Income Loss Net Of Tax | -79000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 43000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 5589000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20250331 | Assets | 94739000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Assets Current | 88735000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 70396000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20231231 | Common Stock Shares Issued | 39625271.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Common Stock Shares Issued | 40132647.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240630 | Common Stock Shares Outstanding | 53245824.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Common Stock Value | 53000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Common Stock Value | 61000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Comprehensive Income Net Of Tax | -17080000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Comprehensive Income Net Of Tax | -45210000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Earnings Per Share Basic | -0.3400 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Earnings Per Share Basic | -0.2700 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Embedded Derivative Fair Value Of Embedded Derivative Liability | 483000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Gain Loss On Derivative Instruments Net Pretax | -41000.0000 | USD | 3 | us-gaap/2024 | Derivative Instrument Risk= Embedded Derivative Financial Instruments; | ||
| 0001558370-25-007582 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 1152000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Net Cash Provided By Used In Operating Activities | -38846000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Net Income Loss | -17050000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Net Income Loss | -50022000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20240331 | Nonoperating Income Expense | -837000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Nonoperating Income Expense | 4022000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Operating Lease Payments | 544000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Operating Lease Right Of Use Asset | 1485000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 122000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20240331 | Receivable From Exercise Of Stock Options | 10000.0000 | USD | 3 | 0001558370-25-007582 | |||
| 0001558370-25-007582 | 20240331 | Research And Development Expense | 12401000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20231231 | Stockholders Equity | 40000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20241231 | Stockholders Equity | 99589000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20241231 | Stockholders Equity | 61000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 3502376.0000 | shares | 1 | 0001558370-25-007582 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250430 | Stock Issued During Period Shares New Issues | 4153846.0000 | shares | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= Underwriters Option; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 271823.0000 | shares | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Value Exercise Of Pre Funded Warrants | 6000.0000 | USD | 3 | 0001558370-25-007582 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 10000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 10000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 10000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 760000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240331 | Stock Repurchased And Retired During Period Value | 5700000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 39910160.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 9578834.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 10939447.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 70031041.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 6828891.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 38722544.0000 | shares | 3 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 3750000.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2024; | ||
| 0001558370-25-007582 | 20241130 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Common Stock Shares Issued | 53245824.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20241231 | Common Stock Shares Issued | 60534695.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Deposits Assets Noncurrent | 2925000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Earnings Per Share Basic | -0.8900 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Earnings Per Share Basic | -0.7200 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Earnings Per Share Diluted | -0.3400 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Earnings Per Share Diluted | -0.2700 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Embedded Derivative Fair Value Of Embedded Derivative Liability | 468000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Embedded Derivative Fair Value Of Embedded Derivative Liability | 500000.0000 | USD | 0 | us-gaap/2024 | Derivative Instrument Risk= Embedded Derivative Financial Instruments; | ||
| 0001558370-25-007582 | 20250331 | General And Administrative Expense | 4740000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Interest And Other Income | 3829000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Interest And Other Income | 1115000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Liabilities Current | 10527000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Net Cash Provided By Used In Operating Activities | -57400000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Net Income Loss | -45483000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20250331 | Net Income Loss | -18914000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20250331 | Operating Expenses | 54044000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 273000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Payments Of Stock Issuance Costs | 293000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Payments Of Stock Issuance Costs | 594000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Property Plant And Equipment Net | 80000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20231231 | Stockholders Equity | 381154000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 6300080.0000 | shares | 3 | 0001558370-25-007582 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 5525267.0000 | shares | 3 | 0001558370-25-007582 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 761000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 50812332.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 51211564.0000 | shares | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 1549573.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2021; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 9578834.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 51211564.0000 | shares | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 1549573.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2021; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 10939447.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 60536988.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 970030.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Exchange Pre Funded Warrants; | ||
| 0001558370-25-007582 | 20250331 | Accounts Payable Current | 6502000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Accrued Clinical Current | 2366000.0000 | USD | 0 | 0001558370-25-007582 | |||
| 0001558370-25-007582 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4750000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 14596000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -55800000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001558370-25-007582 | 20240630 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Employee Related Liabilities Current | 1812000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Gain Loss On Derivative Instruments Net Pretax | -1950000.0000 | USD | 3 | us-gaap/2024 | Derivative Instrument Risk= Warrant Derivative Financial Instruments; | ||
| 0001558370-25-007582 | 20250331 | Gain Loss On Derivative Instruments Net Pretax | -15000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Gain Loss On Derivative Instruments Net Pretax | -15000.0000 | USD | 3 | us-gaap/2024 | Derivative Instrument Risk= Embedded Derivative Financial Instruments; | ||
| 0001558370-25-007582 | 20240331 | General And Administrative Expense | 10667000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | General And Administrative Expense | 13380000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Interest And Other Income | 1122000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Liabilities | 11734000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Net Cash Provided By Used In Financing Activities | -296000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Net Cash Provided By Used In Financing Activities | 6167000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Net Cash Provided By Used In Investing Activities | 29036000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Non Cash Lease Expense | 399000.0000 | USD | 3 | 0001558370-25-007582 | |||
| 0001558370-25-007582 | 20240331 | Nonoperating Income Expense | 1838000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Operating Expenses | 16213000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Operating Expenses | 20023000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Operating Income Loss | -54044000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Operating Lease Liability Current | 568000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Operating Lease Liability Noncurrent | 1160000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 273000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20240331 | Payments To Acquire Marketable Securities | 56730000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Proceeds From Issuance Of Private Placement | 6000000.0000 | USD | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Private Placement; | ||
| 0001558370-25-007582 | 20230630 | Stockholders Equity | 377471000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20230630 | Stockholders Equity | -260985000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20240331 | Stockholders Equity | -78000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20240331 | Stockholders Equity | -306468000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20241231 | Stockholders Equity | 460016000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20250331 | Stockholders Equity | 61000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240630 | Stock Issued During Period Shares New Issues | 1250000.0000 | shares | 0 | us-gaap/2024 | Counterparty Name= Handok Inc.; Related Party Transactions By Related Party= Related Party; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001558370-25-007582 | 20240630 | Stock Issued During Period Shares New Issues | 1786589.0000 | shares | 0 | us-gaap/2024 | Subsidiary Sale Of Stock= Underwriters Option; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 5000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 271823.0000 | shares | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Value Exercise Of Pre Funded Warrants | 3000.0000 | USD | 1 | 0001558370-25-007582 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Value Exercise Of Pre Funded Warrants | -6000.0000 | USD | 3 | 0001558370-25-007582 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value New Issues | 1000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value New Issues | 6000000.0000 | USD | 3 | us-gaap/2024 | Subsidiary Sale Of Stock= Private Placement; | ||
| 0001558370-25-007582 | 20240331 | Stock Repurchased And Retired During Period Value | 5697000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240331 | Stock Repurchased And Retired During Period Value | 3000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 3750000.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2024; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 58229644.0000 | shares | 3 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 70031041.0000 | shares | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 3750000.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2024; | ||
| 0001558370-25-007582 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1903000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1903000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 4750000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20230630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 16036000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 5930000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Common Stock Shares Outstanding | 60542914.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Employee Related Liabilities Current | 1044000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Gain Loss On Derivative Instruments Net Pretax | -1991000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Non Cash Lease Expense | 395000.0000 | USD | 3 | 0001558370-25-007582 | |||
| 0001558370-25-007582 | 20250331 | Prepaid Expense And Other Assets Current | 1843000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 85799000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20230630 | Stockholders Equity | 116172000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20231231 | Stockholders Equity | -48000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20240630 | Stockholders Equity | 121003000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Stockholders Equity | 82569000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Stockholders Equity | 43000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20250331 | Stockholders Equity | -379466000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20250430 | Stock Issued During Period Shares New Issues | 20786923.0000 | shares | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; Subsidiary Sale Of Stock= Underwritten Public Offering; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Value Exercise Of Pre Funded Warrants | -3000.0000 | USD | 1 | 0001558370-25-007582 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value New Issues | 5999000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Additional Paid In Capital; Subsidiary Sale Of Stock= Private Placement; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 10000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 1000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Stock Repurchased And Retired During Period Value | 5700000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 1323338.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2021; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 123000.0000 | shares | 1 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2021; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 69901565.0000 | shares | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 6828891.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20250331 | Earnings Per Share Diluted | -0.7200 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1905000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 45000.0000 | USD | 3 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20230630 | Common Stock Shares Issued | 36827567.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Common Stock Shares Issued | 60542914.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Earnings Per Share Diluted | -0.8900 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Gain Loss On Derivative Instruments Net Pretax | -1959000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Gain Loss On Derivative Instruments Net Pretax | -6000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Interest And Other Income | 4037000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Marketable Securities Current | 72296000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Net Income Loss | -45483000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Nonoperating Income Expense | 1109000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Operating Income Loss | -16213000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Operating Income Loss | -47321000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Operating Income Loss | -20023000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Operating Lease Liability Noncurrent | 1660000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -30000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Preferred Stock Shares Authorized | 400000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240630 | Preferred Stock Value | USD | 0 | us-gaap/2024 | ||||
| 0001558370-25-007582 | 20240630 | Property Plant And Equipment Net | 103000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 352000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20240331 | Share Based Compensation | 5589000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001558370-25-007582 | 20230630 | Stockholders Equity | -351000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20240630 | Stockholders Equity | -79000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20240630 | Stockholders Equity | 450473000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240630 | Stockholders Equity | 53000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240630 | Stockholders Equity | -329444000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20241231 | Stockholders Equity | 64000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001558370-25-007582 | 20241231 | Stockholders Equity | -360552000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001558370-25-007582 | 20241031 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 2999384.0000 | shares | 0 | 0001558370-25-007582 | Class Of Warrant Or Right= Exchange Pre Funded Warrants; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 2525883.0000 | shares | 3 | 0001558370-25-007582 | Class Of Warrant Or Right= Pre Funded Warrants2022; | ||
| 0001558370-25-007582 | 20250331 | Stock Issued During Period Value Exercise Of Pre Funded Warrants | 6000.0000 | USD | 3 | 0001558370-25-007582 | Equity Components= Common Stock; | ||
| 0001558370-25-007582 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 10000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001558370-25-007582 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 38722544.0000 | shares | 3 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 60536988.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0001558370-25-007582 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 970030.0000 | shares | 3 | us-gaap/2024 | Class Of Warrant Or Right= Exchange Pre Funded Warrants; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Receivable From Exercise Of Stock Options | 0001558370-25-007582 | 1 | 0 | monetary | D | D | Receivable From Exercise of Stock Options | Amount of receivable from exercise of stock options in non-cash investing or financing transactions. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Proceeds From Issuance Of Private Placement | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Acquisition Of Treasury Shares In Exchange For Issuing Pre Funded Warrant Liability | 0001558370-25-007582 | 1 | 0 | monetary | D | D | Acquisition Of Treasury Shares In Exchange For Issuing Pre-Funded Warrant Liability | Acquisition of treasury shares in exchange for issuing pre-funded warrant liability |
| Non Cash Lease Expense | 0001558370-25-007582 | 1 | 0 | monetary | D | D | Non Cash Lease Expense | Amount representing the non cash lease expense. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. |
| Stock Repurchased And Retired During Period Shares | us-gaap/2024 | 0 | 0 | shares | D | Stock Repurchased and Retired During Period, Shares | Number of shares that have been repurchased and retired during the period. | |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Marketable Securities Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Operating Lease Payments | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Lease, Payments | Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Stock Repurchased And Retired During Period Value | us-gaap/2024 | 0 | 0 | monetary | D | D | Stock Repurchased and Retired During Period, Value | Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). |
| Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 0001558370-25-007582 | 1 | 0 | shares | D | Stock Issued During Period, Shares, Exercise of Pre-funded Warrants | Number of shares issued upon exercise of pre-funded warrants. | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Employee Related Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Interest And Other Income | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Marketable Securities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities, Noncurrent | Amount of investment in marketable security, classified as noncurrent. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Accrued Clinical Current | 0001558370-25-007582 | 1 | 0 | monetary | I | C | Accrued Clinical, Current | Amount of accrued for clinical liabilities. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Embedded Derivative Fair Value Of Embedded Derivative Liability | us-gaap/2024 | 0 | 0 | monetary | I | C | Embedded Derivative, Fair Value of Embedded Derivative Liability | Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability. |
| Gain Loss On Derivative Instruments Net Pretax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Derivative Instruments, Net, Pretax | Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Payments For Repurchase Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments for Repurchase of Common Stock | The cash outflow to reacquire common stock during the period. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Stock Issued During Period Value Exercise Of Pre Funded Warrants | 0001558370-25-007582 | 1 | 0 | monetary | D | C | Stock Issued During Period, Value, Exercise of Pre-funded Warrants | Value of stock issued upon exercise of pre-funded warrants |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Deposits Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Deposits Assets, Noncurrent | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001558370-25-007582 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001558370-25-007582 | 2 | 4 | BS | 0 | H | Marketable Securities Current | us-gaap/2024 | Investments in marketable debt securities | 0 |
| 0001558370-25-007582 | 2 | 5 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other | 0 |
| 0001558370-25-007582 | 2 | 6 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001558370-25-007582 | 2 | 8 | BS | 0 | H | Deposits Assets Noncurrent | us-gaap/2024 | Deposits and other | 0 |
| 0001558370-25-007582 | 2 | 9 | BS | 0 | H | Marketable Securities Noncurrent | us-gaap/2024 | Investments in marketable debt securities | 0 |
| 0001558370-25-007582 | 2 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Right-of-use assets | 0 |
| 0001558370-25-007582 | 2 | 11 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001558370-25-007582 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001558370-25-007582 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001558370-25-007582 | 2 | 17 | BS | 0 | H | Accrued Clinical Current | 0001558370-25-007582 | Accrued clinical and other | 0 |
| 0001558370-25-007582 | 2 | 18 | BS | 0 | H | Employee Related Liabilities Current | us-gaap/2024 | Compensation and benefits | 0 |
| 0001558370-25-007582 | 2 | 19 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of operating lease liabilities | 0 |
| 0001558370-25-007582 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001558370-25-007582 | 2 | 22 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liabilities, net of current portion | 0 |
| 0001558370-25-007582 | 2 | 23 | BS | 0 | H | Embedded Derivative Fair Value Of Embedded Derivative Liability | us-gaap/2024 | Embedded derivative liability | 0 |
| 0001558370-25-007582 | 2 | 24 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001558370-25-007582 | 2 | 25 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Notes 5, 9 and 10) | 0 |
| 0001558370-25-007582 | 2 | 27 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.001 par value; 400,000 shares authorized; no shares issued | 0 |
| 0001558370-25-007582 | 2 | 28 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value; 165,000,000 and 100,000,000 shares authorized; issued and outstanding 60,542,914 and 53,245,824 shares as of March 31, 2025 and as of June 30, 2024, respectively | 0 |
| 0001558370-25-007582 | 2 | 29 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001558370-25-007582 | 2 | 30 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income (loss) | 0 |
| 0001558370-25-007582 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001558370-25-007582 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders' equity | 0 |
| 0001558370-25-007582 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders' equity | 0 |
| 0001558370-25-007582 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001558370-25-007582 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001558370-25-007582 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares, issued | 0 |
| 0001558370-25-007582 | 3 | 4 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| 0001558370-25-007582 | 3 | 5 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001558370-25-007582 | 3 | 6 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001558370-25-007582 | 3 | 7 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001558370-25-007582 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001558370-25-007582 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001558370-25-007582 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001558370-25-007582 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0001558370-25-007582 | 4 | 7 | IS | 0 | H | Interest And Other Income | us-gaap/2024 | Interest and other income, net | 0 |
| 0001558370-25-007582 | 4 | 8 | IS | 0 | H | Gain Loss On Derivative Instruments Net Pretax | us-gaap/2024 | Loss from change in fair value of derivative liabilities | 0 |
| 0001558370-25-007582 | 4 | 9 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total non-operating income (expense), net | 0 |
| 0001558370-25-007582 | 4 | 10 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001558370-25-007582 | 4 | 12 | IS | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Net unrealized gain (loss) on marketable debt securities | 0 |
| 0001558370-25-007582 | 4 | 13 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0001558370-25-007582 | 4 | 14 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per common share - basic (in dollars per share) | 0 |
| 0001558370-25-007582 | 4 | 15 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per common share - diluted (in dollars per share) | 0 |
| 0001558370-25-007582 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of common shares outstanding - basic (in shares) | 0 |
| 0001558370-25-007582 | 4 | 17 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of common shares outstanding - diluted (in shares) | 0 |
| 0001558370-25-007582 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance beginning | 0 |
| 0001558370-25-007582 | 5 | 13 | EQ | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Balance beginning (in shares) | 0 |
| 0001558370-25-007582 | 5 | 14 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Gross proceeds from issuance of common stock for cash | 0 |
| 0001558370-25-007582 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Gross proceeds from issuance of common stock for cash (in shares) | 0 |
| 0001558370-25-007582 | 5 | 16 | EQ | 0 | H | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2024 | Commissions and other offering costs | 1 |
| 0001558370-25-007582 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Issuance of common stock upon exercise of stock options | 0 |
| 0001558370-25-007582 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Issuance of common stock upon exercise of stock options (in shares) | 0 |
| 0001558370-25-007582 | 5 | 19 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Share-based compensation | 0 |
| 0001558370-25-007582 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value Exercise Of Pre Funded Warrants | 0001558370-25-007582 | Cashless exercise of pre-funded warrants | 0 |
| 0001558370-25-007582 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares Exercise Of Pre Funded Warrants | 0001558370-25-007582 | Cashless exercise of pre-funded warrants (in shares) | 0 |
| 0001558370-25-007582 | 5 | 22 | EQ | 0 | H | Stock Repurchased And Retired During Period Value | us-gaap/2024 | Acquisition and retirement of treasury shares pursuant to Exchange Agreement | 1 |
| 0001558370-25-007582 | 5 | 23 | EQ | 0 | H | Stock Repurchased And Retired During Period Shares | us-gaap/2024 | Acquisition and retirement of treasury shares pursuant to Exchange Agreement (in shares) | 1 |
| 0001558370-25-007582 | 5 | 24 | EQ | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Net change in accumulated other comprehensive income (loss) | 0 |
| 0001558370-25-007582 | 5 | 25 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001558370-25-007582 | 5 | 26 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance ending | 0 |
| 0001558370-25-007582 | 5 | 27 | EQ | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Balance ending (in shares) | 0 |
| 0001558370-25-007582 | 6 | 8 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001558370-25-007582 | 6 | 9 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation expense | 0 |
| 0001558370-25-007582 | 6 | 10 | CF | 0 | H | Gain Loss On Derivative Instruments Net Pretax | us-gaap/2024 | Loss from change in fair value of derivative liabilities | 1 |
| 0001558370-25-007582 | 6 | 11 | CF | 0 | H | Non Cash Lease Expense | 0001558370-25-007582 | Non-cash lease expense | 0 |
| 0001558370-25-007582 | 6 | 12 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Accretion of discounts and amortization of premiums on marketable debt securities, net | 1 |
| 0001558370-25-007582 | 6 | 13 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation expense | 0 |
| 0001558370-25-007582 | 6 | 15 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Increase in prepaid expenses, deposits, and other assets | 1 |
| 0001558370-25-007582 | 6 | 16 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Increase in accounts payable | 0 |
| 0001558370-25-007582 | 6 | 17 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Increase (decrease) in accrued liabilities | 0 |
| 0001558370-25-007582 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net Cash Used in Operating Activities | 0 |
| 0001558370-25-007582 | 6 | 20 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchase of marketable debt securities | 1 |
| 0001558370-25-007582 | 6 | 21 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Proceeds from maturities of marketable debt securities | 0 |
| 0001558370-25-007582 | 6 | 22 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Total Cash Provided by (Used in) Investing Activities | 0 |
| 0001558370-25-007582 | 6 | 24 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of stock options | 0 |
| 0001558370-25-007582 | 6 | 25 | CF | 0 | H | Payments For Repurchase Of Common Stock | us-gaap/2024 | Net cash payment pursuant to Exchange Agreement | 1 |
| 0001558370-25-007582 | 6 | 26 | CF | 0 | H | Proceeds From Issuance Of Private Placement | us-gaap/2024 | Gross proceeds from issuance of common stock in 2024 Private Placement | 0 |
| 0001558370-25-007582 | 6 | 27 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Payment of offering costs | 1 |
| 0001558370-25-007582 | 6 | 28 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net Cash Provided by (Used in) Financing Activities | 0 |
| 0001558370-25-007582 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net decrease in cash and cash equivalents | 0 |
| 0001558370-25-007582 | 6 | 30 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0001558370-25-007582 | 6 | 31 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0001558370-25-007582 | 6 | 33 | CF | 0 | H | Operating Lease Payments | us-gaap/2024 | Cash paid for amounts included in the measurement of operating lease liabilities | 0 |
| 0001558370-25-007582 | 6 | 34 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | Operating lease liabilities incurred in exchange for right-of-use-assets | 0 |
| 0001558370-25-007582 | 6 | 36 | CF | 0 | H | Acquisition Of Treasury Shares In Exchange For Issuing Pre Funded Warrant Liability | 0001558370-25-007582 | Acquisition of treasury shares in exchange for issuing pre-funded warrant liability | 0 |
| 0001558370-25-007582 | 6 | 37 | CF | 0 | H | Receivable From Exercise Of Stock Options | 0001558370-25-007582 | Receivable from exercise of stock options | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |